Posted On: 06/19/2014 11:42:55 AM
Post# of 30066
Re: biotechexpert #1088
This is reality.
Quote:
While these experiments are underway, with data expected in the next several weeks, we are concurrently putting together the necessary orphan regulatory expertise to apply for Orphan Drug Designation (ODD) with the FDA. We expect to be in a position to file for ODD with the FDA for MANF in Retinitis Pigmentosa shortly after receiving the final data sets over the summer.
(0)
(0)
